查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1619482

2024 年心臟標記測試全球市場報告

Cardiac Marker Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

心臟標記檢測市場規模預計在未來幾年將快速成長。 2028年，將以10.2%的複合年成長率成長至93.5億美元。預測期內的成長可歸因於心血管疾病患病率的上升、戰略聯盟和夥伴關係數量的增加、研發舉措的擴大、有利的報銷政策以及對照護現場(POC) 檢測的需求不斷成長。預測期內預計的主要趨勢包括診斷技術的進步、自動分析儀的使用、先進心臟標記檢測方法的開發、數位健康技術的整合以及整合技術的出現。

心血管疾病的日益普及預計將在未來幾年推動心臟標記檢測市場的成長。心血管疾病 (CVD) 包括冠狀動脈疾病、心臟衰竭和中風等影響心臟和血管的疾病。不健康飲食、缺乏運動、吸菸、過量飲酒和空氣污染等因素導致心血管疾病病例增加。心臟標記檢測在診斷心血管疾病、評估嚴重程度以及透過檢測心肌損傷期間釋放的特定生物標記監測治療進展方面發揮著重要作用。例如，美國心臟協會2024年1月報告稱，心血管疾病的年齡調整死亡率增加了4.0%，從2023年的每10萬人224.4人死亡增加到每10萬人233.3人。此外，2021 年美國有 20,114 人死於心臟麻痹。因此，心血管疾病發生率的增加推動了對心臟標記檢測的需求。

心臟標記檢測市場的主要企業專注於開發先進的產品，例如心臟檢測，提供有關心臟健康和功能的準確且有價值的資訊。這些檢測是診斷測試，旨在測量血液或其他樣本中的生物標記和其他指標，以幫助評估心臟功能、診斷心血管疾病並評估心臟相關疾病的風險。例如，2023年10月，中國醫療設備公司邁瑞宣布推出肌鈣蛋白I（hs-cTnI）和NT-proBNP心臟生物標記。 hs-cTnI 檢測在第99 個百分位數的檢測極限(LoD) 和參考上限(URL) 之間實現了93% 的檢出率，第99 個百分位數的不精確變異係數(CV) ≤ 5% URL以其高靈敏度、高精度、高可靠性而受到關注，超越了最低要求。因此，它對於檢測心肌損傷非常有效。邁瑞的 NT-proBNP檢測法是心臟衰竭的關鍵心臟標記物，提供 CV<=5% 的高精度，最大限度地減少 55 種常見心臟治療的干擾，並為心臟衰竭提供準確的診斷。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球心臟標記測試市場：促進因素和限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球心臟標記檢測市場表現：規模與成長，2018-2023
  • 全球心臟標記測試市場預測：規模和成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球心臟標記測試市場：按產品、性能和預測，2018-2023、2023-2028、2033
  • 試劑和套件
  • 裝置
  • 全球心臟標記測試市場：按生物標記類型分類的表現和預測，2018-2023、2023-2028、2033
  • 肌鈣蛋白 I 和 T
  • 肌酸激酶-MB (CK-MB)
  • 利尿鈉肽
  • 肌紅蛋白
  • 高敏C反應蛋白
  • 其他心臟生物標記
  • 全球心臟標記測試市場：按應用、性能和預測分類，2018-2023、2023-2028、2033
  • 實驗室測試設施
  • 就地檢驗設施
  • 學術機構

第 7 章 區域/國家分析

  • 全球心臟標記測試市場：按地區、表現和預測，2018-2023、2023-2028、2033
  • 全球心臟標記檢測市場：按國家、表現和預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 心臟標記檢測市場：競爭格局
  • 心臟標記測試市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第31章 其他大型創新企業

  • Becton Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • Tosoh Corporation
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Guangzhou Wondfo BIoTech Co. Ltd.
  • Randox laboratories Ltd.
  • Getein BIoTech Inc.
  • Fujirebio Inc.
  • Mayo Clinic Laboratories
  • Kainos Medicine Inc.
  • Alere Inc.
  • Nano-Ditech Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20513

Cardiac marker testing involves a series of diagnostic tests designed to measure specific substances in the blood that signal damage or stress to the heart. These markers, often proteins or enzymes, are released into the bloodstream when the heart muscle is injured. Cardiac marker tests are vital for diagnosing and assessing conditions such as myocardial infarction (heart attack), heart failure, and other heart-related diseases.

The primary products used in cardiac marker testing include reagents, kits, and instruments. Reagents and kits are crucial components in these tests, containing the necessary chemicals and materials for conducting diagnostics. They provide various biomarkers, such as troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptide, myoglobin, high-sensitivity C-reactive protein, and others, and are utilized in laboratory testing facilities, point-of-care testing facilities, and academic institutions.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $5.92 billion in 2023 to $6.52 billion in 2024 at a compound annual growth rate (CAGR) of 10%. The growth during the historical period can be attributed to the increase in the geriatric population, the rise in educational campaigns, growing awareness, the expansion of healthcare infrastructure, and the increasing patient population.

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the rising incidence of cardiovascular diseases, increasing strategic collaborations and partnerships, expanding research and development initiatives, favorable reimbursement policies, and growing demand for point-of-care (POC) testing. Key trends anticipated in the forecast period include advancements in diagnostic technologies, the use of automated analyzers, the development of advanced cardiac marker testing assays, the integration of digital health technologies, and the emergence of integrative technologies.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiac marker testing market in the coming years. Cardiovascular diseases (CVDs), encompassing conditions such as coronary artery disease, heart failure, and stroke, affect the heart and blood vessels. Factors such as unhealthy diets, lack of physical activity, tobacco use, excessive alcohol consumption, and air pollution contribute to the rise in CVD cases. Cardiac marker testing plays a crucial role in diagnosing cardiovascular diseases, assessing their severity, and monitoring treatment progress by detecting specific biomarkers released during myocardial injury. For instance, the American Heart Association reported in January 2024 that the age-adjusted death rate from cardiovascular disease increased by 4.0%, from 224.4 per 100,000 in 2023 to 233.3 per 100,000. Additionally, sudden cardiac arrest accounted for 20,114 deaths in the U.S. in 2021. As a result, the growing incidence of cardiovascular diseases is fueling the demand for cardiac marker testing.

Leading companies in the cardiac marker testing market are focusing on the development of advanced products, such as cardiac assays, to provide accurate and valuable information regarding heart health and function. These assays are diagnostic tests designed to measure biomarkers or other indicators in blood or other samples, helping to assess heart function, diagnose cardiovascular diseases, and evaluate the risk of heart-related conditions. For example, in October 2023, Mindray, a medical device company based in China, introduced the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay is notable for its high sensitivity, precision, and reliability, surpassing the minimum requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL), and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL. This makes it highly effective in detecting myocardial injury. Mindray's NT-proBNP assay is a key cardiac marker for heart failure, offering high precision with a CV of <=5% and minimizing interference from 55 common heart disease medications, ensuring accurate detection and management of heart failure.

In August 2024, VION Biosciences, a US-based life sciences platform, acquired Ansh Labs for an undisclosed amount. This acquisition is intended to bolster VION Biosciences' presence in the diagnostic sector, integrate advanced technologies, and expand its product offerings in immunoassay development. Ansh Labs is a US-based biotechnology company.

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

North America was the largest region in the cardiac marker testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Instruments
  • 2) By Biomarker Type: Troponin I And T; Creatine Kinase-MB (CK-MB); Natriuretic Peptide; Myoglobin; High-Sensitivity C-Reactive Protein; Other Cardiac Biomarkers
  • 3) By Application: Laboratory Testing Facilities; Point-Of-Care Testing Facilities; Academic Institutions
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Marker Testing Market Characteristics

3. Cardiac Marker Testing Market Trends And Strategies

4. Cardiac Marker Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cardiac Marker Testing Market Size and Growth

  • 5.1. Global Cardiac Marker Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiac Marker Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiac Marker Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac Marker Testing Market Segmentation

  • 6.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents And Kits
  • Instruments
  • 6.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Troponin I And T
  • Creatine Kinase-MB (CK-MB)
  • Natriuretic Peptide
  • Myoglobin
  • High-Sensitivity C-Reactive Protein
  • Other Cardiac Biomarkers
  • 6.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratory Testing Facilities
  • Point-Of-Care Testing Facilities
  • Academic Institutions

7. Cardiac Marker Testing Market Regional And Country Analysis

  • 7.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac Marker Testing Market

  • 8.1. Asia-Pacific Cardiac Marker Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac Marker Testing Market

  • 9.1. China Cardiac Marker Testing Market Overview
  • 9.2. China Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac Marker Testing Market

  • 10.1. India Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac Marker Testing Market

  • 11.1. Japan Cardiac Marker Testing Market Overview
  • 11.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac Marker Testing Market

  • 12.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac Marker Testing Market

  • 13.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac Marker Testing Market

  • 14.1. South Korea Cardiac Marker Testing Market Overview
  • 14.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac Marker Testing Market

  • 15.1. Western Europe Cardiac Marker Testing Market Overview
  • 15.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac Marker Testing Market

  • 16.1. UK Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac Marker Testing Market

  • 17.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac Marker Testing Market

  • 18.1. France Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac Marker Testing Market

  • 19.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac Marker Testing Market

  • 20.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac Marker Testing Market

  • 21.1. Eastern Europe Cardiac Marker Testing Market Overview
  • 21.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac Marker Testing Market

  • 22.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac Marker Testing Market

  • 23.1. North America Cardiac Marker Testing Market Overview
  • 23.2. North America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac Marker Testing Market

  • 24.1. USA Cardiac Marker Testing Market Overview
  • 24.2. USA Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac Marker Testing Market

  • 25.1. Canada Cardiac Marker Testing Market Overview
  • 25.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac Marker Testing Market

  • 26.1. South America Cardiac Marker Testing Market Overview
  • 26.2. South America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac Marker Testing Market

  • 27.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac Marker Testing Market

  • 28.1. Middle East Cardiac Marker Testing Market Overview
  • 28.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac Marker Testing Market

  • 29.1. Africa Cardiac Marker Testing Market Overview
  • 29.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Marker Testing Market Competitive Landscape
  • 30.2. Cardiac Marker Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cardiac Marker Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Laboratory Corporation of America Holdings
  • 31.3. Quest Diagnostics Inc.
  • 31.4. Tosoh Corporation
  • 31.5. bioMerieux SA
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Guangzhou Wondfo Biotech Co. Ltd.
  • 31.9. Randox laboratories Ltd.
  • 31.10. Getein Biotech Inc.
  • 31.11. Fujirebio Inc.
  • 31.12. Mayo Clinic Laboratories
  • 31.13. Kainos Medicine Inc.
  • 31.14. Alere Inc.
  • 31.15. Nano-Ditech Corporation

32. Global Cardiac Marker Testing Market Competitive Benchmarking

33. Global Cardiac Marker Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

35. Cardiac Marker Testing Market Future Outlook and Potential Analysis

  • 35.1 Cardiac Marker Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Marker Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Marker Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer